Inhaled corticosteroids (ICS) are the mainstay of treatment for asthma, but their role in
chronic obstructive pulmonary disease (COPD) is debated. Recent randomised controlled …

Purpose Complications of pneumonia development in patients with chronic obstructive
pulmonary disease (COPD) receiving inhaled corticosteroid (ICS) therapy have been …

Background Pneumonia is an important complication of COPD and is reported more often in
patients receiving inhaled corticosteroids (ICSs). Little is known about the clinical course …

Background Inhaled corticosteroids (ICS) have been shown to decrease the occurrence of
COPD exacerbations. However, the relationship of baseline lung function and reduction of …

The aim of this study was to investigate whether inhaled corticosteroid (ICS) use affects
outcome in patients with chronic obstructive pulmonary disease (COPD) admitted with …

Objectives International guidelines only advocate the use of inhaled corticosteroids (ICSs) in
patients with chronic obstructive pulmonary disease (COPD) experiencing recurring …

Background. Studies have suggested an increased risk of pneumonia with inhaled
corticosteroid (ICS) use, although this association is inconsistent. We evaluated the risk of …

Rationale: Inhaled corticosteroids are commonly prescribed to patients with chronic
obstructive pulmonary disease (COPD). Objectives: To examine whether these medications …

Background The use of inhaled corticosteroids (ICS) in combination with bronchodilators in
patients with COPD has been shown to decrease the rate of disease exacerbations and to …

Background Inhaled corticosteroids (ICS) are widely used and recommended to treat
chronic obstructive pulmonary disease (COPD). While generally considered safe, several …